| Sara Lynn Johnson, APN | |
|
544 W Pershing Rd, Decatur, IL 62526-3226 | |
| (217) 872-2400 | |
| Not Available |
| Full Name | Sara Lynn Johnson |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 8 Years |
| Location | 544 W Pershing Rd, Decatur, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831616770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 209.016335 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Iowa Hospital Corporation | 1052229275 | 159 |
News Archive
Caught up in the congressional politics swirling around a pending tax bill are two proposals to extend — once again — subsidies for COBRA health insurance and a 'fix' of Medicare payments to doctors.
Scientists from the Netherlands and the US recently studied the localization of the SARS-CoV-2 proteins in postmortem lung tissues of COVID-19 patients and in SARS-CoV-2 infected Vero cells that were processed identically. The research is posted to the bioRxiv* preprint server, prior to peer review.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way.
› Verified 4 days ago
| Entity Name | Central Iowa Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104879576 PECOS PAC ID: 1052229275 Enrollment ID: O20040128001102 |
News Archive
Caught up in the congressional politics swirling around a pending tax bill are two proposals to extend — once again — subsidies for COBRA health insurance and a 'fix' of Medicare payments to doctors.
Scientists from the Netherlands and the US recently studied the localization of the SARS-CoV-2 proteins in postmortem lung tissues of COVID-19 patients and in SARS-CoV-2 infected Vero cells that were processed identically. The research is posted to the bioRxiv* preprint server, prior to peer review.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sara Lynn Johnson, APN 324 Kings Mantle Ct, Mt Zion, IL 62549-9725 Ph: (641) 485-8398 | Sara Lynn Johnson, APN 544 W Pershing Rd, Decatur, IL 62526-3226 Ph: (217) 872-2400 |
News Archive
Caught up in the congressional politics swirling around a pending tax bill are two proposals to extend — once again — subsidies for COBRA health insurance and a 'fix' of Medicare payments to doctors.
Scientists from the Netherlands and the US recently studied the localization of the SARS-CoV-2 proteins in postmortem lung tissues of COVID-19 patients and in SARS-CoV-2 infected Vero cells that were processed identically. The research is posted to the bioRxiv* preprint server, prior to peer review.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Exelixis, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute's Cancer Therapy Evaluation Program (CTEP) for further evaluation of cabozantinib, Exelixis' lead compound, in a variety of solid tumors.
People who carry a malfunctioning copy of a particular gene are especially good at clearing fat from their systems. The report in the December Cell Metabolism, a Cell Press publication, shows how the mutant gene influences metabolism in this way.
› Verified 4 days ago
Dr. Gretchen L Byrkit, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: One Memorial Dr, Ste 216, Decatur, IL 62526 Phone: 217-875-5574 Fax: 217-875-5724 | |
Jeffrey Pfeiffer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 544 West Pershing Road, Suite A, Decatur, IL 62526 Phone: 217-872-2400 | |
Vidya Sagar Rao Morisetty, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 675 E Snyder Dr Ste 1, Decatur, IL 62526 Phone: 217-875-1886 Fax: 217-875-3120 | |
Roy Tsuda, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: One Memorial Drive, Suite 300, Decatur, IL 62526 Phone: 217-875-5565 Fax: 217-875-4680 | |
Trevor D. Lineberry, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: One Memorial Drive, Suite 300, Decatur, IL 62526 Phone: 217-875-5545 Fax: 217-875-4680 | |
Dr. Douglas Venice Combs, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 320 E Central Ave, Decatur, IL 62521 Phone: 217-545-8000 | |
Pierre Michael Johnson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Suite 300, Decatur, IL 62526 Phone: 217-872-2400 Fax: 217-875-4680 |